Penn scientists discovered three genetic variants that may help the immune system fight Alzheimer’s—and that may be targetable with drugs.

Medidata is making new conquests in the clinical trial world, as it just inked a deal to manage site payments for Worldwide Clinical Trials.

York University scientists have found that beta blockers could potentially reverse heart failure.

QuintilesIMS’ Orchestrated Customer Engagement software aims to build synergies among commercial teams.

OmniComm Systems, which owns early-phase clinical trial electronic data capture software TrialOne, has nailed a major CRO deal worth $11.7 million.

Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.

Oxford Nanopore, which markets the world’s only portable DNA sequencer, has reeled in $126 million through a private placement. This new funding brings the…

A collaborative effort has developed a synthetic viral genome for bone cancer research and may prove revolutionary in the battle against cancer overall.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.

IT